Prudentia Sciences, an AI-powered technology platform for life sciences announced its public launch, supported by $7 million in funding. The funding round was led by GV, with participation from Iaso Ventures and Virtue. The company aims to empower biopharma companies to accelerate drug
IRIS delivers data-driven, actionable insights across the Narvar platform, empowering retailers to engage customers, streamline operations and drive profitable growth through intelligent personalization Narvar, the #1 platform for intelligent personalization “beyond buy,” unveiled IRIS (Intelligent Retail Insights Service) and Narvar
Bluesight, the leading provider of inventory management, procurement, and compliance solutions for health systems and hospital pharmacies, announced the acquisition of Protenus, provider of the leading healthcare compliance analytics platform. This strategic acquisition will further strengthen Bluesight’s drug diversion platform
Brought to you by
To repurpose or use any of the content or material on this and our sister sites, explicit written permission needs to be sought.
